OAS3 is a Co-Immune Biomarker Associated With Tumour Microenvironment, Disease Staging, Prognosis, and Treatment Response in Multiple Cancer Types

• Xin-yu Li,
• Xin-yu Li,
• Lei Hou,
• Lu-yu Zhang,
• Liming Zhang,
• Deming Wang,
• Zhenfeng Wang,
• Ming-Zhe Wen,
• Xi-tao Yang

Affiliations

Xin-yu Li

Department of Interventional Therapy, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Xin-yu Li

Department of Neurosurgery, Shanghai Ninth People’s Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China

Lei Hou

Jiading District Central Hospital Affiliated Shanghai University of Medicine and Health Sciences, Shanghai, China

Lu-yu Zhang

Department of Urologic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

Liming Zhang

Department of Interventional Therapy, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Deming Wang

Department of Interventional Therapy, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Zhenfeng Wang

Department of Interventional Therapy, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Ming-Zhe Wen

Department of Interventional Therapy, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Xi-tao Yang

Department of Interventional Therapy, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China